FA
GSK icon

FMA Advisory’s GSK GSK Stock Holding History

FMA Advisory’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$146K Buy
+2,812
New +$158K 0.09% 120

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FMA Advisory's GSK Position: Q2 2015 in Review

FMA Advisory opened a new position in GSK (GSK) in Q2 2015: 2,812 shares worth $146K. The stake represents 0.09% of the portfolio and ranks #120 among its holdings.

719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

  • FMA Advisory held 2,812 shares of GSK worth $146K as of Q2 2015.
  • GSK was a new FMA Advisory position in Q2 2015.
  • GSK made up 0.09% of FMA Advisory's portfolio in Q2 2015, its #120 holding.
  • 719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on FMA Advisory's 13F filing for Q2 2015, filed 17 Dec 2019.